Skip to main content
. 2020 Oct 22;10:18128. doi: 10.1038/s41598-020-75141-2

Figure 2.

Figure 2

Serum levels of advanced oxidation protein products (AOPPs) and ischaemia-modified albumin (IMA) in patients with drug-induced liver injury before and after treatment. (A) AOPPs levels in the non-severe group. (B) AOPPs levels in the severe group. (C) IMA levels in the non-severe group. (D) IMA levels in the severe group. ***P < 0.001. ABSU absorbance units.